Terms: = Endocrine gland cancer AND PBX1, P40424, 5087 AND Treatment
5 results:
1. A novel c-Kit/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3-pbx1 and β-catenin-ABCG2 signaling.
Fang CH; Lin YT; Liang CM; Liang SM
J Biomed Sci; 2020 Mar; 27(1):42. PubMed ID: 32169072
[TBL] [Abstract] [Full Text] [Related]
2. Is there an oligometastatic state in pancreatic cancer? Practical clinical considerations raise the question.
Scorsetti M; Comito T; Franceschini D; Franzese C; Prete MG; D'Alessio A; Bozzarelli S; Rimassa L; Santoro A
Br J Radiol; 2020 Feb; 93(1106):20190627. PubMed ID: 31825664
[TBL] [Abstract] [Full Text] [Related]
3. Ovarian cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor pbx1.
Jung JG; Shih IM; Park JT; Gerry E; Kim TH; Ayhan A; Handschuh K; Davidson B; Fader AN; Selleri L; Wang TL
Cancer Res; 2016 Nov; 76(21):6351-6361. PubMed ID: 27590741
[TBL] [Abstract] [Full Text] [Related]
4. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer.
Marin-Muller C; Li D; Bharadwaj U; Li M; Chen C; Hodges SE; Fisher WE; Mo Q; Hung MC; Yao Q
Clin Cancer Res; 2013 Nov; 19(21):5901-13. PubMed ID: 23989979
[TBL] [Abstract] [Full Text] [Related]
5. Prevalence and incidence of comorbidities in elderly women with ovarian cancer.
Chia VM; O'Malley CD; Danese MD; Lindquist KJ; Gleeson ML; Kelsh MA; Griffiths RI
Gynecol Oncol; 2013 May; 129(2):346-52. PubMed ID: 23422502
[TBL] [Abstract] [Full Text] [Related]